Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-003078

Options or other derivatives

  • Director acquired 8,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cockroft Bettina M. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-05 Grant or award : show line 1 in the form Option to purchase common stock +8,300 8,300 D
Loading xslF345X04/ownership.xml…